Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.7 USD | +2.39% | +1.68% | +20.83% |
05-15 | Merck to present new oncology data | CF |
05-14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.83% | 326B | |
+31.37% | 588B | |
-2.60% | 364B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B | |
+0.89% | 124B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. - Shareholder/Analyst Call